Search

Your search keyword '"Schubert, S."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Schubert, S." Remove constraint Author: "Schubert, S." Topic escherichia coli Remove constraint Topic: escherichia coli
31 results on '"Schubert, S."'

Search Results

1. Two Polyketides Intertwined in Complex Regulation: Posttranscriptional CsrA-Mediated Control of Colibactin and Yersiniabactin Synthesis in Escherichia coli.

2. Major role of iron uptake systems in the intrinsic extra-intestinal virulence of the genus Escherichia revealed by a genome-wide association study.

3. A simple and highly efficient method for gene silencing in Escherichia coli.

4. Contribution of yersiniabactin to the virulence of an Escherichia coli sequence type 69 ("clonal group A") cystitis isolate in murine models of urinary tract infection and sepsis.

5. Investigation of horizontal gene transfer of pathogenicity islands in Escherichia coli using next-generation sequencing.

6. Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.

7. Strain-specific impact of the high-pathogenicity island on virulence in extra-intestinal pathogenic Escherichia coli.

8. The salmochelin receptor IroN itself, but not salmochelin-mediated iron uptake promotes biofilm formation in extraintestinal pathogenic Escherichia coli (ExPEC).

9. Interplay between siderophores and colibactin genotoxin biosynthetic pathways in Escherichia coli.

10. Activity of moxifloxacin, imipenem, and ertapenem against Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, and Bacteroides fragilis in monocultures and mixed cultures in an in vitro pharmacokinetic/pharmacodynamic model simulating concentrations in the human pancreas.

11. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS).

12. Prevalence and phylogenetic history of the TcpC virulence determinant in Escherichia coli.

13. Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species.

14. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.

15. Aspects of genome plasticity in pathogenic Escherichia coli.

16. The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro.

17. Characterization of four novel genomic regions of uropathogenic Escherichia coli highly associated with the extraintestinal virulent phenotype: a jigsaw puzzle of genetic modules.

18. Distribution and characteristics of Escherichia coli clonal group A.

19. A novel integrative and conjugative element (ICE) of Escherichia coli: the putative progenitor of the Yersinia high-pathogenicity island.

20. The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis.

21. Identification of novel virulence-associated loci in uropathogenic Escherichia coli by suppression subtractive hybridization.

22. Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection.

23. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.

24. Characterization of an iroBCDEN gene cluster on a transmissible plasmid of uropathogenic Escherichia coli: evidence for horizontal transfer of a chromosomal virulence factor.

25. Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections.

26. Distribution of the outer membrane haem receptor protein ChuA in environmental and human isolates of Escherichia coli.

27. Internalization of extraintestinal Escherichia coli O18 strains by epithelial cells is modulated by EGF, insulin, and effectors of transmembrane signal transduction.

28. HPI of high-virulent Yersinia is found in E. coli strains causing urinary tract infection. Structural, functional aspects, and distribution.

29. A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages.

30. Characterization of the integration site of Yersinia high-pathogenicity island in Escherichia coli.

31. Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans.

Catalog

Books, media, physical & digital resources